حول
Are we failing to treat a large population of men who would benefit from hormone replacement therapy? Moreover, there are no data suggesting that testosterone supplementation into the normal physiological range leads to an increased risk of developing prostate cancer. In elderly and middle aged men with coronary disease, about one-quarter will have testosterone deficiency and symptomatic hypogonadism.42 In men with coronary disease, it remains unclear what role testosterone deficiency might play in the aetiology and progression of atherosclerosis or whether hypotestosteronaemia simply reflects chronic illness and frailty. If the Basaria trial had been done in hypothyroid patients with high cardiovascular risk and replacement had aimed at supra-physiological levels, the same (or worse) results would have been seen. The literature showed that testosterone replacement should be managed in the same way as thyroid hormone replacement. Hopefully, the current article has dealt with the former concern and has brought reassurance regarding physiological levels of testosterone and the male heart.One treatment available for many of these problems is spironolactone, a special type of diuretic (water pill) that blocks the action of male sex hormones. In addition, what may seem like a symptom of testosterone excess (see below) may actually be unrelated to this hormone. Blood levels of testosterone vary dramatically over time and even during the course of a day. The proper balance between testosterone (along with other androgens) and estrogen is important for the ovaries to work normally. These hormones are thought to have important effects on
A "feedback loop" closely regulates the amount of hormone in the blood. The pituitary gland then relays signals to the testes to produce testosterone. Signals sent from the brain to the pituitary gland at the base of the brain control the production of testosterone in men. It is essential to the development of male growth and masculine characteristics. Learn all about the sex hormone here, including its primary benefits. There's more to testosterone than guys behaving badly. When you think of testosterone, what comes to mind?
Your hypothalamus and pituitary gland control the amount of testosterone your gonads (testicles or ovaries) produce and release. Testosterone triggers the development of the male internal and external reproductive organs during fetal development. At around week seven in utero, the sex-related gene on the Y chromosome initiates the development of the testicles in male infants.
They concluded that TRT for hypogonadism does not appear to increase PSA or the risk of prostate cancer. No significant adverse CV events were noted.28 Further studies are needed to evaluate the clinical effects of TRT in CHF, but testosterone appears to be a promising therapeutic option for patients with CHF. Testosterone replacement therapy has been shown to significantly improve exercise capacity without affecting left ventricular ejection fraction (LVEF). All three found that in men with CAD, testosterone prolongs the time to exercise-induced ST-segment depression as measured on treadmill stress testing.24–26 Testosterone has been reported to have direct vasodilatory effects on coronary arteries in men with CAD.26 In its assessment of CV risks and T therapy, the FDA identified a total of only 4 studies suggesting an increased risk, yet none provided solid evidence to support this. The association varied across the individual components of MetS and was strongest with hypertriglyceridemia, abdominal obesity, and hyperglycemia.14 It has been well established that men with type 2 diabetes have lower levels of T compared to men without diabetes.11 Population-based studies have revealed that men with the lowest quartile of endogenous serum T concentrations are at double the risk of developing type 2 diabetes and MetS.6 9 Finally, Corona et al. screened 1,178 articles and found 70 in their meta-analysis that showed a clear association between low T/high estradiol levels and CV disease.10 Longitudinal studies demonstrated that overall mortality and CV mortality were highest in those with low T levels.
It typically results from narrowed arteries (atherosclerosis), heart attack, heart valve diseases or infections that weaken the heart muscle. The observed improvements need to be reproduced in larger numbers of patients before testosterone can be recommended as therapy, said Dr. Justin Z. Ezekowitz, director of the Heart Function Clinic at the University of Alberta in Edmonton, Canada. However, the pooled findings are from only 198 patients with chronic, stable heart failure, so they hardly provide the final word on treating the disorder with hormonal supplements, the study's lead author said. Although 84 percent of the study subjects, with an average age of 67, were men, testosterone treatment with patches, gels or injections also produced improvements in women. Some study participants experienced 50 percent improvements in their ability to walk and in some cases, the muscle-strengthening effects lasted a year. Also testosterone is known to stimulate growth of prostate cancer in men diagnosed with the condition.
